The German Cardiosurgery Atrial Fibrillation Registry: 1-Year Follow-up Outcomes.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
06 2023
Historique:
medline: 25 5 2023
pubmed: 28 7 2022
entrez: 27 7 2022
Statut: ppublish

Résumé

This study of German Cardiosurgery Atrial Fibrillation (CASE-AF) registry aims to describe the 1-year outcomes of patients undergoing ablative procedures for atrial fibrillation (AF) in a cardiosurgical setting. Between January 2017 and April 2020, 17 German cardiosurgical units enrolled 1,000 consecutive patients undergoing concomitant or stand-alone ablation for AF. In-hospital and 1-year follow-up data were collected on web-based electronic case report forms. The protocol mandated telephone-based follow-up contact after 1 year. At 1-year follow-up (median, 14.5 months [12.6-18.2 months]), significant improvement ( Surgical ablation of AF is safe and provides satisfactory results at short-term follow-up, with significant improvement in patient symptoms. Adequate cardiac rhythm monitoring should be prioritized for higher quality data acquisition.

Identifiants

pubmed: 35896439
doi: 10.1055/s-0042-1750311
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-263

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Mahmoud Wehbe (M)

Schüchtermann-Schiller'sche Hospital Group Bad Rothenfelde, Bad Rothenfelde, Germany.

Marc Albert (M)

Department of Cardiac Surgery, Robert-Bosch-Krankenhaus GmbH, Stuttgart, Baden-Württemberg, Germany.

Thorsten Lewalter (T)

Peter Osypka Herzzentrum - Internal Medicine München Süd, München, Germany.

Taoufik Ouarrak (T)

Stiftung für Herzinfarkt Forschung, Bremserstraße 79, Ludwigshafen am Rhein, Germany.

Jochen Senges (J)

Stiftung für Herzinfarkt Forschung, Bremserstraße 79, Ludwigshafen am Rhein, Germany.

Thorsten Hanke (T)

Universitätsklinikum Schleswig-Holstein, Campus Lübeck - Asklepios Klinik Harburg, Hamburg, Germany.

Nicolas Doll (N)

Department of Cardiac Surgery, Schüchtermann-Schiller'sche Hospital Group Bad Rothenfelde, Bad Rothenfelde, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH